PLATINUM INVESTMENT MANAGEMENT LTD
Position in COGT — Cogent Biosciences, Inc.
CIK 1256071
SYDNEY AUSTRALIA 2000, C3
Position in COGT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,968,314
+$1,654,894 QoQ
Shares Held
154,220
+37.6% QoQ
Ownership
0.089%
of shares outstanding
% of Portfolio
1.47%
of 13F equity value
Holder Rank
#119
of 321 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in COGT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PLATINUM INVESTMENT MANAGEMENT LTD holds $78,056,040 across 25 Biotechnology names. COGT ranks #2 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
58,314 | $7,740,017 | |
| 2 | COGT |
Cogent Biosciences, Inc.
This page
|
154,220 | $5,968,314 | |
| 3 | IMVT |
Immunovant, Inc.
|
144,671 | $5,574,173 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
64,752 | $5,277,935 | |
| 5 | IDYA |
IDEAYA Biosciences, Inc.
|
138,708 | $5,169,647 | |
| 6 | VERA |
Vera Therapeutics, Inc.
|
113,687 | $4,878,309 | |
| 7 | GPCR |
Structure Therapeutics Inc.
|
90,363 | $4,849,782 | |
| 8 | RCUS |
Arcus Biosciences, Inc.
|
134,217 | $4,137,910 |
All Filings in COGT
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,968,314 | 154,220 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $4,313,420 | 112,066 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,306,054 | 121,229 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,152,077 | 219,504 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,576,038 | 219,504 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $802,120 | 133,910 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,231,237 | 157,851 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,704,790 | 157,851 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,330,683 | 157,851 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,251,626 | 186,254 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,796,727 | 475,634 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,639,410 | 475,837 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $5,648,627 | 477,080 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $5,147,693 | 477,080 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,911,668 | 511,390 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $7,629,938 | 511,390 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,130,736 | 901,412 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $7,869,735 | 1,050,699 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $9,014,997 | 1,050,699 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $8,261,126 | 982,298 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $6,699,825 | 826,119 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $6,426,108 | 731,903 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $5,342,167 | 475,705 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||